The Pharmaceutical Journal | Is Amazon Really a Threat to the UK Pharmacy Market?
May 2021
Matthew Lee, Managing Director at Lincoln International joins the Pharmaceutical Journal deputy news editor, Carolyn Wickware, in a recent episode of The PJ Pod to share his thoughts on the future for community pharmacy in the UK, as Amazon Pharmacy prepares to enter the market.
Summary
-
Matthew Lee, Managing Director at Lincoln International was featured on the Pharmaceutical Journal's Podcast, The PJ Pod, to discuss the long-term view for community pharmacy as Amazon Pharmacy gets a UK trademark.
- Sign up to receive Lincoln's perspectives
Contributor
Meet Professionals with Complementary Expertise in Healthcare
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk-Oliver Löffler
Managing Director | Management Board Member
Frankfurt
Related Perspectives in Healthcare
Real Deals | Healthcare M&A Resilience
What trends have you seen in the last quarter in relation to valuations in the healthcare space? Matthew Lee: It’s early days to get an accurate read on valuations as… Read More
Lincoln International Announces Strategic Partnership with Australian Corporate Advisory Firm, Miles Advisory Partners
Lincoln International, a global investment banking advisory firm, announced today that it has established a strategic partnership with Miles Advisory Partners, an Australian-based independent corporate advisory firm, servicing the robust… Read More
Lincoln International’s Global Healthcare Group Announces Strong Results in 2022
Lincoln International’s global Healthcare Group enjoyed another consecutive year of record-setting mergers and acquisitions (M&A) deal volume, average deal size and a record backlog heading in to 2023. Our performance… Read More
Scrip | What Does 2023 Hold for Biopharma? Part 6: Artificial Intelligence
Originally posted by Scrip on February 10, 2023. Tony Crisman, Managing Director in Lincoln’s Healthcare Group, shares his predictions for artificial intelligence in the biopharma industry. View the original article.
